Keyphrases
COVID-19
95%
Wales
61%
United Kingdom
50%
Vaccination
46%
Confidence Interval
39%
Healthcare Workers
34%
Influenza
33%
Seroepidemiology
32%
Europe
27%
Antimicrobial Resistance
26%
Primary Care
25%
Age Groups
24%
Haemophilus Influenzae Type b
23%
Vaccine Effectiveness
23%
Antibiotic Use
22%
Respiratory Syncytial Virus
21%
Antibiotics
20%
Measles
19%
COVID-19 Pandemic
19%
Antimicrobial Use
19%
Risk Factors
19%
SARS-CoV-2 Infection
19%
Epidemiology
18%
Meningococcal Disease
18%
Vaccination Coverage
18%
Infection Rate
17%
Vaccination Program
17%
Lateral Flow Device
17%
Siren
17%
Conjugate Vaccine
16%
Influenza Season
15%
Invasive Pneumococcal Disease
15%
Hospital Admission
15%
COVID-19 Vaccine
15%
Mumps
15%
Point Prevalence Survey
14%
Acute Hospital
14%
Vaccination Campaign
14%
Hepatitis C Virus Infection
13%
National Surveillance
13%
Vaccine Failure
12%
Neisseria Meningitidis
12%
Healthcare-associated Infections
12%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
12%
European Countries
12%
European Economic Area
12%
European Union
12%
Hepatitis C Virus
11%
SARS-CoV-2 Variants
11%
Meningococcal C Conjugate Vaccine
11%
Third Dose
11%
Influenza A
11%
Influenza Vaccination
11%
Pertussis
11%
Hospitalization
11%
Seroprevalence
10%
Antibiotic Prescribing
10%
Virus
10%
Immunogenicity
10%
Surveillance System
10%
Childhood Vaccination
10%
Measles-mumps-rubella
10%
Hepatitis B
10%
Excess Mortality
10%
Seasonal Influenza
10%
4CMenB
10%
Vaccine Uptake
10%
Two-dose
10%
Rubella
9%
Adjusted Odds Ratio
9%
Asymptomatic Infection
9%
Neutralizing Antibodies
9%
Serum Samples
9%
Western Europe
9%
Influenza-like Illness
9%
PCR Test
9%
BNT162b2
9%
Surveillance Data
9%
Escherichia Coli
9%
Hepatitis C
9%
Primary School children
9%
Disease Control
9%
Unvaccinated
9%
Antibody Response
9%
Public Health
9%
Serogroup C
9%
High Risk
8%
Immunization Programs
8%
General Practice
8%
Disease Burden
8%
Attack Rate
8%
World Health Organization
8%
Polymerase Chain Reaction
8%
Vaccine Program
8%
Omicron Variant
8%
Serosurvey
8%
Reinfection
8%
Surveillance Program
8%
Hospitalized Patients
8%
Quantitative PCR
8%
Medicine and Dentistry
Infection
100%
Severe Acute Respiratory Syndrome Coronavirus 2
74%
COVID-19
65%
Diseases
61%
Prevalence
34%
Antibiotic Resistance
30%
Serotype
27%
Primary Health Care
24%
Meningococcal Disease
21%
Public Health
19%
Human Respiratory Syncytial Virus
18%
Antibiotics
15%
Cohort Effect
14%
Influenza Vaccine
14%
Systematic Review
14%
Hepatitis C
13%
Neisseria meningitidis
13%
Pathogen
13%
Pediatrics
13%
COVID-19 Vaccine
12%
Cross Sectional Study
12%
Polymerase Chain Reaction
12%
Conjugate Vaccine
12%
Antiinfective Agent
12%
Measles
11%
Hepatitis B
11%
Observational Study
11%
Haemophilus Influenzae Type B
11%
Odds Ratio
10%
Virus
10%
Randomized Controlled Trial
10%
Cohort Analysis
9%
Respiratory Tract Infection
9%
Seasonal Influenza
9%
Pertussis
9%
Hepatitis C Virus
9%
Influenza Vaccination
9%
Healthcare Associated Infection
8%
Health Care
8%
Surveillance System
8%
Secondary Care
8%
Reinfection
8%
Influenza A Virus (H3N2)
7%
Severe Acute Respiratory Syndrome
7%
Immune Response
7%
Influenza B
7%
Escherichia coli
7%
Seroepidemiology
6%
Virus Surveillance
6%
Respiratory Disease
6%
Meta-Analysis
6%
Health Care Cost
6%
Influenza A
6%
Booster Dose
6%
Emergency Care
5%
Bloodstream Infection
5%
Logistic Regression Analysis
5%
Neutralizing Antibody
5%
Carbapenemase
5%
Beta-Lactamase
5%
Mortality Rate
5%
Pneumococcal Infection
5%
Case-Control Study
5%
T Cell
5%
High Risk Population
5%
Diphtheria Vaccine
5%
Sepsis
5%
Meningococcus Vaccine
5%
Awareness
5%
Men Who Have Sex with Men
5%
Antiviral Therapy
5%
Urinary Tract Infection
5%
Influenza A Virus (H1N1)
5%
Evaluation Study
5%